Related references
Note: Only part of the references are listed.Prospective analysis of pain expectancy and experience during MR-fusion prostate biopsy: does reality match patients' expectancy?
Philipp Krausewitz et al.
WORLD JOURNAL OF UROLOGY (2022)
The main sources of circulating cell-free DNA: Apoptosis, necrosis and active secretion
Zijian Hu et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)
Natural history of widespread high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: should we rebiopsy them all?
Marco Oderda et al.
SCANDINAVIAN JOURNAL OF UROLOGY (2021)
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet et al.
EUROPEAN UROLOGY (2021)
Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies
Cora Palanca-Ballester et al.
CANCERS (2021)
Analysis of the Prognostic Value and Gene Expression Mechanism of SHOX2 in Lung Adenocarcinoma
Nanhong Li et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Tumor-Associated Release of Prostatic Cells into the Blood after Transrectal Ultrasound-Guided Biopsy in Patients with Histologically Confirmed Prostate Cancer
Simon A. Joosse et al.
CLINICAL CHEMISTRY (2020)
MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis
Michael Ahdoot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Treatment Response Monitoring in Patients with Advanced Malignancies Using Cell-Free SHOX2 and SEPT9 DNA Methylation in Blood An Observational Prospective Study
Luka de Vos et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2020)
Cell-Free DNA-Methylation-Based Methods and Applications in Oncology
Francesca Galardi et al.
BIOMOLECULES (2020)
Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2
Baris Turkbey et al.
EUROPEAN UROLOGY (2019)
Multicenter Optimization and Validation of a 2-Gene mRNA Urine Test for Detection of Clinically Significant Prostate Cancer before Initial Prostate Biopsy
Alexander Haese et al.
JOURNAL OF UROLOGY (2019)
The Diagnosis and Treatment of Prostate Cancer A Review
Mark S. Litwin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease
Gunter Weiss et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients
Luka de Vos et al.
CLINICAL EPIGENETICS (2017)
Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study
Andreas Schroeck et al.
CLINICAL CHEMISTRY (2017)
Development of Castration Resistant Prostate Cancer can be Predicted by a DNA Hypermethylation Profile
Javier C. Angulo et al.
JOURNAL OF UROLOGY (2016)
Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients
Andra Kuskel et al.
SCIENTIFIC REPORTS (2016)
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer
Timothy Robert Church et al.
GUT (2014)
Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates
Dimo Dietrich et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer:: a meta-analysis
A. M. Hovels et al.
CLINICAL RADIOLOGY (2008)
Prostate cancer: psychosocial implications and management
Andrew J. Roth et al.
FUTURE ONCOLOGY (2008)
Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (PSA) levels <10 ng/mL -: The PSA negative patients
AJ Birtle et al.
CANCER (2003)
Share Paper
